Moderna Inc. has asked U.S. health regulators to authorize the use of its Covid-19 vaccine in children ages 6 months to 5 years old.
The company said Thursday that it had submitted the request after a study showed the shot safely induced immune responses in the young age group.
To Read the Full Story
